Bicara Therapeutics Inc. Common Stock (BCAX) vs IRadimed Corporation (IRMD)

A side-by-side comparison of Bicara Therapeutics Inc. Common Stock and IRadimed Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Bicara Therapeutics Inc. Common Stock logo
BCAX
Bicara Therapeutics Inc. Common Stock
$1.12B
$17.08HealthcareDelayed quote: Oct 6, 2026, 10:00 AM EDT
IRadimed Corporation logo
IRMD
IRadimed Corporation
$1.10B
$86.01HealthcareDelayed quote: Oct 6, 2026, 10:00 AM EDT

Total return — BCAX vs IRMD

growth of $100 · dividends reinvested · last 2y
BCAX -26.1% (-14.1%/yr)IRMD +89.8% (+37.8%/yr)IRMD compounded faster over this window
50100150200Start $10020252026$74$190
BCAX IRMD

BCAX vs IRMD: by the numbers

  • •BCAX is the larger company ($1.12B vs $1.10B market cap).
  • •IRMD is profitable (26.70% net margin) while BCAX runs a net loss (0.00%).
  • •IRMD pays a dividend (1.47% yield), while BCAX has no payments in the available dividend history.

Metrics side by side

Valuation

MetricBCAXIRMD
P/E ratioN/A48.05
Forward P/EN/A40.70
PEG ratioN/A0.65
P/S ratioN/A12.73
P/B ratio2.3910.81
EV / EBITDAN/A35.37
FCF yieldN/A2.27%

Profitability

MetricBCAXIRMD
Gross margin0.00%75.86%
Operating margin0.00%31.92%
Net margin0.00%26.70%
ROE-39.54%22.66%
ROIC-42.98%20.18%

Dividends

MetricBCAXIRMD
Dividend yieldN/A1.47%
Payout ratioN/A70.95%

Growth (annualized)

MetricBCAXIRMD
Revenue CAGR (5Y)N/A19.60%
EPS CAGR (5Y)N/A74.32%
FCF CAGR (5Y)N/A26.20%
Total return CAGR (5Y)N/A24.06%

Frequently asked

Does BCAX or IRMD pay a bigger dividend?
IRMD pays a dividend (1.47% yield), while BCAX has no payments in the available dividend history.
Is BCAX or IRMD more profitable?
IRMD runs the higher net margin — BCAX at 0.00% versus IRMD at 26.70%.

Go deeper

Full BCAX analysisFull IRMD analysisInteractive comparison tool

Dig into the metrics

IRadimed P/E ratioIRadimed dividend yieldBicara Therapeutics Inc. Common Stock ROEIRadimed ROEBicara Therapeutics Inc. Common Stock operating marginIRadimed operating marginBicara Therapeutics Inc. Common Stock revenue growthIRadimed revenue growthBicara Therapeutics Inc. Common Stock free cash flowIRadimed free cash flow

Bicara Therapeutics Inc. Common Stock & IRadimed appear in these rankings

Fastest Revenue Growth StocksHighest ROIC StocksHighest Operating Margin StocksHighest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.